Close

Content

• “The procedure of importing drugs to Ukraine is slightly bloated … But I do not consider such scrupulousness as a big disadvantage”

  Is there more responsible business than pharmaceutical? After all, usually, at the heart of any commercial project is the desire to earn. How to be in a situation where entrepreneurial activity is not just a pursuit of profit, but an important social mission? Andrey Deineko - head of the pharmaceutical company Aspen in Ukraine, and in the past - a practicing surgeon,  answered all these questions to business publication LDaily.

• “Who will invest in a country where military actions are taking place? Either one who strongly believes in success, or one who sees the future”

  In a conversation with LDaily, CEO explained why the domestic pharmaceutical industry has increased its capacity during the crisis, and that an investor who is not afraid to enter the Ukrainian market.

• «The formulary system should work on international names, not on trademarks»

  A story of India native Rajeev Gupta, who was not afraid to start his business in a foreign country

• Neither government nor Ministry of Healthcare understands how to implement Health Care Reform for the patient’s benefit

  Valeriy Kondruk, the president of “Pharmplaneta” company, explains why foreign pharmaceutical companies are ready to return to Ukraine only after 2025

• Tetiana Pechaeva: “Pharmaceutical industry demands reforms”

  Tetiana Pechaeva, CEO of the Lekhim group of companies, told why health care reform could fail

• “The success of the pharmaceutical business in Ukraine depends directly on the welfare of the population”

  How business protects its interests, uniting the efforts of other companies, explained the president of the «Operators of medical products market» Association Pavlo Kharchyk in his interview

• “Pharmaceutical business in Ukraine is an attractive sector for investments”

  Vladimir Redko, executive director of the Association of Pharmaceutical Research and Development "APRaD" told about tendencies of health care reform

• “The crisis has become a springboard for flexible pharmaceutical companies which are ready for dynamic strategic decisions”

  The Ukrainian pharmaceutical market has lived through difficult times, which made its players evolve to survive the crisis. Nevertheless, there were exceptions: those who were not ready to make strategic decisions - dropped out of the game. Or, on the contrary, he used crisis excitements for a new round of business development. The  LDaily journalist met with Stanislav Dyachenko, the director of the STADA Representative Office in Ukraine to get to know the pharmaceutical industry from the inside and discuss how the pharmaceutical companies managed to overcome the difficult times for the industry

• «Many tools for earning money by the officials arise in a regulated system»

  How the Producers of Medical Equipment and Medical Devices Committee of the American Chamber of Commerce protects the interests of foreign business in Ukraine tells Mykola Romaniok, Head of the Chamber Working Group, in an interview with LDaily

• “In 2017, the pharmaceutical market is showing a significant growth, with growing both local and foreign companies”

  Top-management GlaxoSmithKline Pharmaceutical Ukraine (GSK) talking about culture of ethics in Ukraine pharmaceutical market

• “Trust of patients – the main criterion for conducting pharmaceutical business”

  Marketing director of the company "Bionorika" Anatolii Pasichnyk tells about the pharmaceutical business, crisis, investment attractiveness of Ukraine and democratic management in the company

• “Pharmaceutical business is a highly intellectual business, which has no place for reckless and spontaneous decisions”

  Managing partner of the group of companies Cratiya, LLC Maxim Bagreev about the modern ways of pharmaceutical development in the country

• “We should realize that the pharmacy is a healthcare institution, not a point of purchase”

  Head of the Board of All-Ukrainian Pharmaceutical Chamber, member of the International Pharmaceutical Federation (FIP) Oleg Klimov opened the dark side of the Ukrainian pharmacy business in a sharp as a needle interview for LDaily  

• “A rooted model of behavior prevents Ukraine from building a perfect business”

  Honest conversation with Mykola Siutkin, founder and CEO of S&P Investment Risk Management Agency about the different worldviews that business creates for itself.